ESC 365 - Are target doses relevant for women with heart failure? - implications for sacubitril-valsartan

HFA Premium Access

Are target doses relevant for women with heart failure? - implications for sacubitril-valsartan

Session: Patient management - From oral treatment to transplant

Topic: Pharmacotherapy

Speaker: Mrs H. Norberg (Umea, SE)

Event: Heart Failure 2018

Congress Presentation

Add to my library

About the speaker

Mrs Helena Norberg

Umea University, Umea (Sweden)

0 follower

14 more presentations in this session

Structured follow-up program of patients with heart failure: impact on quality of life and prognosis.

Speaker: Doctor J. AGOSTINHO (Lisbon, PT)

Impact of physicians' adherence to guideline-recommended therapy on heart failure re-hospitalizations: data from the Optimize Heart Failure Care Program

Speaker: Doctor A. Grebennikova (Volgograd, RU)

Perceptions of heart failure treatment decision-making and side effects of heart failure treatment by patients and cardiologists: a multinational survey in the real-world cardiology setting

Speaker: Doctor S. Bruce Wirta (Stockholm, SE)

CANCELLED - The effect of home-based cardiac rehabilitation following coronary artery bypass graft surgery in a low income country: A controlled trial

Speaker: Mr J. Uddin (Dhaka, BD)

The optimal plasma volume status in heart failure in relation to clinical outcome

Speaker: Doctor P. Martens (Genk, BE)

Access the full session

Patient management - From oral treatment to transplant

Speakers: Mrs H. Norberg, Doctor J. AGOSTINHO, Doctor A. Grebennikova, Doctor S. Bruce Wirta, Mr J. Uddin...

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources